Table 3 County trends (P < 0.01) by state in seroprevalence of antibodies to Borrelia burgdorferi
State (n)a | Counties with decreasing trend n (%) | Counties with increasing trend n (%) | Counties with no change n (%) |
|---|---|---|---|
Majority counties decreasing | |||
Connecticut (n = 8) | 5 (62.5) | 2 (25.0) | 1 (12.5) |
Delaware (n = 3) | 3 (100.0) | 0 | 0 |
Massachusetts (n = 14) | 11 (78.6) | 1 (7.1) | 2 (14.3) |
Maryland (n = 23) | 19 (82.6) | 1 (4.3) | 3 (13.0) |
New Jersey (n = 21) | 14 (66.7) | 1 (4.8) | 6 (28.6) |
Rhode Island (n = 5) | 4 (80.0) | 0 | 1 (20.0) |
Majority counties increasing | |||
New York (n = 60) | 9 (15.0) | 32 (53.3) | 19 (31.7) |
West Virginia (n = 33) | 3 (9.1) | 21 (63.6) | 9 (27.3) |
Mixed county trends | |||
Iowa (n = 43) | 3 (7.0) | 13 (30.2) | 27 (63.0) |
Illinois (n = 54) | 8 (14.0) | 6 (11.0) | 40 (74.0) |
Indiana (n = 52) | 6 (11.5) | 11 (21.2) | 35 (67.3) |
Kentucky (n = 41) | 2 (4.9) | 9 (22.0) | 30 (73.2) |
Maine (n = 16) | 2 (12.5) | 7 (43.8) | 7 (43.8) |
Michigan (n = 60) | 7 (11.7) | 14 (23.3) | 39 (65.0) |
Minnesota (n = 47) | 15 (31.9) | 3 (6.4) | 29 (61.7) |
North Carolina (n = 70) | 17 (24.3) | 12 (17.1) | 41 (58.6) |
North Dakota (n = 8) | 0 | 1 (12.5) | 7 (87.5) |
New Hampshire (n = 10) | 3 (30.0) | 4 (40.0) | 3 (30.0) |
Ohio (n = 60) | 6 (10.0) | 22 (36.7) | 32 (53.3) |
Pennsylvania (n = 61) | 20 (32.8) | 27 (44.3) | 14 (23.0) |
South Carolina (n = 23) | 1 (4.3) | 3 (13.0) | 19 (82.6) |
Tennessee (n = 37) | 1 (2.7) | 5 (13.5) | 31 (83.8) |
Virginia (n = 86) | 31 (36.0) | 8 (9.3) | 47 (54.7) |
Vermont (n = 12) | 3 (25.0) | 4 (33.3) | 5 (41.7) |
Wisconsin (n = 58) | 24 (41.4) | 8 (13.8) | 26 (44.8) |